Page 1047 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

4 References

91. Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to 103. Labelle AJ, Arnold H, Reichley RM, Micek ST, Kollef MH.
reduce patients’ exposure to antibiotics in intensive care units A comparison of culture-positive and culture-negative
(PRORATA trial): a multicentre randomised controlled trial. health-care-associated pneumonia. Chest. 2010;137(5):1130-1137.
Lancet. 2010;375(9713):463-474. 104. Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Prediction of
92. Yende S, D’Angelo G, Mayr F, et al. Elevated hemostasis markers infection due to antibiotic-resistant bacteria by select risk fac-
after pneumonia increases one-year risk of all-cause and cardio- tors for health care-associated pneumonia. Arch Intern Med.
vascular deaths. PLoS One. 2011;6(8):e22847. 2008;168(20):2205-2210.
93. King MD, Whitney CG, Parekh F, Farley MM. Recurrent inva- 105. Schlueter M, James C, Dominguez A, Tsu L, Seymann G.
sive pneumococcal disease: a population-based assessment. Clin Practice patterns for antibiotic de-escalation in culture-negative
Infect Dis. 2003;37(8):1029-1036. healthcare-associated pneumonia. Infection. 2010;38(5):357-362.
94. American Thoracic Society; Infectious Diseases Society of America. 106. El-Solh AA, Pietrantoni C, Bhat A, et al. Microbiology of severe
Guidelines for the management of adults with hospital-acquired, aspiration pneumonia in institutionalized elderly. Am J Respir
ventilator-associated, and healthcare-associated pneumonia. Am J Crit Care Med. 2003;167(12):1650-1654.
Respir Crit Care Med. 2005;171(4):388-416. 107. Kett D, Cano E, Quartin A, et al. Implementation of guidelines
95. Friedman ND, Kaye KS, Stout JE, et al. Health care–associated for management of possible multidrug-resistant pneumonia
bloodstream infections in adults: a reason to change the in intensive care: an observational, multicentre cohort study.
accepted definition of community-acquired infections. Ann Lancet Infect Dis. 2011;11(3):181-189.
Intern Med. 2002;137(10):791-797. 108. Azoulay E, Mokart D, Lambert J, et al. Diagnostic strategy
96. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. for hematology and oncology patients with acute respiratory
Health care-associated pneumonia and community-acquired failure: randomized controlled trial. Am J Respir Crit Care Med.
pneumonia: a single-center experience. Antimicrob Agents 2010;182(8):1038-1046.
Chemother. 2007;51(10):3568-3573. 109. Sopena N, Sabria M. Multicenter study of hospital-acquired
97. Carratala J, Mykietiuk A, Fernandez-Sabe N, et al. Health care- pneumonia in non-ICU patients. Chest. 2005;127(1):213-219.
associated pneumonia requiring hospital admission: epidemiol- 110. Herer B, Fuhrman C, Gazevic Z, Cabrit R, Chouaid C.
ogy, antibiotic therapy, and clinical outcomes. Arch Intern Med. Management of nosocomial pneumonia on a medical ward:
2007;167(13):1393-1399. a comparative study of outcomes and costs of invasive proce-
98. El Solh AA, Pietrantoni C, Bhat A, Bhora M, Berbary E. dures. Clin Microbiol Infect. 2009;15(2):165-172.
Indicators of potentially drug-resistant bacteria in severe nursing 111. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV,
home-acquired pneumonia. Clin Infect Dis. 2004;39(4):474-480. Kollef MH. Linezolid vs vancomycin: analysis of two double-blind
99. Sugisaki M, Enomoto T, Shibuya Y, et al. Clinical char- studies of patients with methicillin-resistant Staphylococcus
acteristics of healthcare-associated pneumonia in a public aureus nosocomial pneumonia. Chest. 2003;124(5):1789-1797.
hospital in a metropolitan area of Japan. J Infect Chemother. 112. Wunderink RG, Niederman MS, Kollef MH, et al. Linezolid
2012;18(3):352-360. in methicillin-resistant Staphylococcus aureus nosocomial
100. Attridge RT, Frei CR, Restrepo MI, et al. Guideline-concordant pneumonia: a randomized, controlled study. Clin Infect Dis.
therapy and outcomes in healthcare-associated pneumonia. 2012;54(5):621-629.
Eur Respir J. 2011;38(4):878-887. 113. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days
101. Depuydt P, Putman B, Benoit D, Buylaert W, De Paepe P. of antibiotic therapy for ventilator-associated pneumonia in
Nursing home residence is the main risk factor for increased adults: a randomized trial. JAMA. 2003;290(19):2588-2598.
mortality in healthcare-associated pneumonia. J Hosp Infect.
2011;77(2):138-142.
102. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS.
Epidemiology and outcomes of health-care-associated pneu-
monia: results from a large US database of culture-positive
pneumonia. Chest. 2005;128(6):3854-3862.

Section05-O-ref.indd 4 1/20/2015 4:51:18 PM